Expression of cyclooxygenase-2 and inducible nitric oxide synthase in human ovarian tumors and tumor-associated macrophages.

Abstract:

:This study investigates whether and to what extent cyclooxygenase type-2 (COX-2) and inducible nitric oxide-synthase (iNOS), both known to have an immunosuppressive effect, are expressed in human ovarian tumors. Because COX-2 and iNOS can be expressed by activated macrophages, the presence of tumor-associated macrophages and the expression of COX-2 and iNOS by these tumor-associated macrophages were determined. The results obtained may provide insight into the function of COX-2 and iNOS expression by tumors. The expression of COX-2 and iNOS in tumor cells and macrophages was assessed in 18 malignant, 15 borderline, and 14 benign human ovarian tumors by immunohistochemical staining of frozen tissue sections. The intra- and peritumoral macrophages were stained using an anti-CD68 monoclonal antibody. Most of the malignant tumors (15 of 18), 10 of 15 borderline, and 9 of 14 benign tumors showed COX-2 expression in the epithelial cells, a result which indicates that COX-2 expression is not exclusive to malignancy. In addition, COX-2 staining was more intense in the epithelial cells of benign and borderline tumors than in malignant tumors. Weak iNOS staining was observed in 5 of 18 malignant, 4 of 15 borderline, and 5 of 14 benign tumors. The number of tumor-associated macrophages varied widely between the different tumors. The highest number of tumor-associated macrophages (> or =20/0.125 mm(2)) was observed in malignant tumors, whereas low to moderate intra- and peritumoral macrophage infiltration (5-20/0.125 mm(2)) was observed in the borderline and benign tumors. COX-2-positive tumor-associated macrophages were found in 3 of 18 malignant tumors, 7 of 15 borderline tumors, and 1 of 14 benign tumors. The number of COX-2-positive tumor-associated macrophages ranged from 3 to 30% of the total macrophage population. Some malignant (4 of 18), borderline (5 of 15), and benign (2 of 14) tumors contained iNOS-positive macrophages. Notable was that COX-2- and iNOS-positive macrophages were predominantly located in the tumor stroma, the regions between tumor and stroma, and in the lumina of the tumor when located in the tumor tissue. These data indicate that not only malignant but also borderline and benign ovarian tumors can exhibit increased levels of COX-2 and iNOS expression. In addition, a small proportion of the tumor-associated macrophages found in malignant, borderline, and benign tumors seems to be in an activated state, judged by their iNOS and COX-2 expression. This subpopulation of tumor-associated macrophages was invariably located in the tumor stroma or in the lumina of the tumor, specifically suggesting that macrophages outside the tumor can be tumor cytotoxic.

journal_name

Cancer Res

journal_title

Cancer research

authors

Klimp AH,Hollema H,Kempinga C,van der Zee AG,de Vries EG,Daemen T

subject

Has Abstract

pub_date

2001-10-01 00:00:00

pages

7305-9

issue

19

eissn

0008-5472

issn

1538-7445

journal_volume

61

pub_type

杂志文章
  • Dietary fat and its relationship to large bowel cancer.

    abstract::Epidemiological data have provided clues to the etiological factors involved in large bowel cancer development. High intake of dietary fat tends to promote colon carcinogenesis. Studies in metabolic epidemiology have shown that the high dietary fat affects the metabolic activity of gut bacteria as well as the levels o...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Reddy BS

    更新日期:1981-09-01 00:00:00

  • Nestin Mediates Hedgehog Pathway Tumorigenesis.

    abstract::The intermediate filament protein Nestin serves as a biomarker for stem cells and has been used to identify subsets of cancer stem-like cells. However, the mechanistic contributions of Nestin to cancer pathogenesis are not understood. Here, we report that Nestin binds the hedgehog pathway transcription factor Gli3 to ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-16-1547

    authors: Li P,Lee EH,Du F,Gordon RE,Yuelling LW,Liu Y,Ng JM,Zhang H,Wu J,Korshunov A,Pfister SM,Curran T,Yang ZJ

    更新日期:2016-09-15 00:00:00

  • The Wilms' tumor antigen is a novel target for human CD4+ regulatory T cells: implications for immunotherapy.

    abstract::Compelling evidences indicate a key role for regulatory T cells (T(reg)) on the host response to cancer. The Wilms' tumor antigen (WT1) is overexpressed in several human leukemias and thus considered as promising target for development of leukemia vaccine. However, recent studies indicated that the generation of effec...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-08-0050

    authors: Lehe C,Ghebeh H,Al-Sulaiman A,Al Qudaihi G,Al-Hussein K,Almohareb F,Chaudhri N,Alsharif F,Al-Zahrani H,Tbakhi A,Aljurf M,Dermime S

    更新日期:2008-08-01 00:00:00

  • A novel senescence-evasion mechanism involving Grap2 and Cyclin D interacting protein inactivation by Ras associated with diabetes in cancer cells under doxorubicin treatment.

    abstract::Ras associated with diabetes (Rad) is a Ras-related GTPase that promotes cell growth by accelerating cell cycle transitions. Rad knockdown induced cell cycle arrest and premature senescence without additional cellular stress in multiple cancer cell lines, indicating that Rad expression might be critical for the cell c...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-09-3791

    authors: Lee I,Yeom SY,Lee SJ,Kang WK,Park C

    更新日期:2010-06-01 00:00:00

  • Glioblastoma induces vascular endothelial cells to express telomerase in vitro.

    abstract::Angiogenesis is essential for the growth of solid tumors. We have observed previously that the vascular endothelial cells of astrocytic brain tumors express human telomerase reverse transcriptase (hTERT) mRNA, suggesting a role for telomerase in the angiogenesis of these neoplasms. Here, we used an in vitro model to d...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Falchetti ML,Pierconti F,Casalbore P,Maggiano N,Levi A,Larocca LM,Pallini R

    更新日期:2003-07-01 00:00:00

  • Small interfering RNA-mediated reduction in heterogeneous nuclear ribonucleoparticule A1/A2 proteins induces apoptosis in human cancer cells but not in normal mortal cell lines.

    abstract::To prevent their recognition as DNA breaks, the ends of linear chromosomes are organized into telomeres, which are made of proteins bound to telomere-specific, double-stranded repeats and to single-stranded DNA extensions, the G-tails. The mammalian heterogeneous nuclear ribonucleoparticule A1 and A2 proteins can bind...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Patry C,Bouchard L,Labrecque P,Gendron D,Lemieux B,Toutant J,Lapointe E,Wellinger R,Chabot B

    更新日期:2003-11-15 00:00:00

  • Metabolic activation of temozolomide measured in vivo using positron emission tomography.

    abstract::The purpose of this research was to quantitate and confirm the mechanism of in vivo metabolic activation of temozolomide. The secondary aims were to evaluate the tumor, normal tissue, and plasma pharmacokinetics of temozolomide in vivo, and to determine whether such pharmacokinetics resulted in tumor targeting. [(11)C...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Saleem A,Brown GD,Brady F,Aboagye EO,Osman S,Luthra SK,Ranicar AS,Brock CS,Stevens MF,Newlands E,Jones T,Price P

    更新日期:2003-05-15 00:00:00

  • Vascular endothelial growth factor--a positive and negative regulator of tumor growth.

    abstract::Over the past decade, the well-documented role of vascular endothelial growth factor (VEGF) in tumor angiogenesis has led it to become one of the leading therapeutic targets for the treatment of cancer. Emerging evidence from genetically modified animal models, however, suggests that elevated levels of VEGF, or a proa...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-09-3592

    authors: Vecchiarelli-Federico LM,Cervi D,Haeri M,Li Y,Nagy A,Ben-David Y

    更新日期:2010-02-01 00:00:00

  • Mitotic Vulnerability in Triple-Negative Breast Cancer Associated with LIN9 Is Targetable with BET Inhibitors.

    abstract::Triple-negative breast cancers (TNBC) are highly aggressive, lack FDA-approved targeted therapies, and frequently recur, making the discovery of novel therapeutic targets for this disease imperative. Our previous analysis of the molecular mechanisms of action of bromodomain and extraterminal protein inhibitors (BETi) ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-17-1571

    authors: Sahni JM,Gayle SS,Webb BM,Weber-Bonk KL,Seachrist DD,Singh S,Sizemore ST,Restrepo NA,Bebek G,Scacheri PC,Varadan V,Summers MK,Keri RA

    更新日期:2017-10-01 00:00:00

  • Early B-cell differentiation in Merkel cell carcinomas: clues to cellular ancestry.

    abstract::Merkel cell carcinoma (MCC) is a highly malignant neuroendocrine nonmelanoma skin cancer, which is associated with the Merkel cell polyoma virus (MCPyV). Recently, expression of the terminal deoxynucleotidyl transferase (TdT) and the paired box gene 5 (PAX 5) has been consistently reported in the majority of MCCs. We ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-13-0616

    authors: Zur Hausen A,Rennspiess D,Winnepenninckx V,Speel EJ,Kurz AK

    更新日期:2013-08-15 00:00:00

  • Plasma DNA microsatellites as tumor-specific markers and indicators of tumor progression in melanoma patients.

    abstract::Multiple DNA microsatellites with frequent loss of heterozygosity (LOH) in melanomas have been demonstrated. The finding that free DNA is enriched in blood of melanoma patients prompted studies to determine whether tumor-specific DNA, such as DNA microsatellites exhibiting LOH, can be detected in blood and have clinic...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Fujiwara Y,Chi DD,Wang H,Keleman P,Morton DL,Turner R,Hoon DS

    更新日期:1999-04-01 00:00:00

  • Phase I-II study of epirubicin in multiple myeloma.

    abstract::Forty patients with relapsed (26) or refractory (14) myeloma were treated with epirubicin of doses of 75, 90, 105, and 120 mg/m2 in groups of 6 or more patients to test for response, maximum tolerated dose, and toxicity. Thirteen patients had received prior doxorubicin and were included in the dose findings part of th...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Case DC Jr,Ervin TJ,Gams R,Sonneborn HL,Paul SD,Oldham FB

    更新日期:1988-11-01 00:00:00

  • Rescue of p53 function by small-molecule RITA in cervical carcinoma by blocking E6-mediated degradation.

    abstract::Proteasomal degradation of p53 by human papilloma virus (HPV) E6 oncoprotein plays a pivotal role in the survival of cervical carcinoma cells. Abrogation of HPV-E6-dependent p53 destruction can therefore be a good strategy to combat cervical carcinomas. Here, we show that a small-molecule reactivation of p53 and induc...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-09-2787

    authors: Zhao CY,Szekely L,Bao W,Selivanova G

    更新日期:2010-04-15 00:00:00

  • Extracellular-Regulated Protein Kinase 5-Mediated Control of p21 Expression Promotes Macrophage Proliferation Associated with Tumor Growth and Metastasis.

    abstract::The presence of immunosuppressive macrophages that become activated in the tumor microenvironment constitutes a major factor responsible for tumor growth and malignancy. In line with this knowledge, we report here that macrophage proliferation is a significant feature of advanced stages of cancer. Moreover, we have fo...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-19-2416

    authors: Giurisato E,Lonardi S,Telfer B,Lussoso S,Risa-Ebrí B,Zhang J,Russo I,Wang J,Santucci A,Finegan KG,Gray NS,Vermi W,Tournier C

    更新日期:2020-08-15 00:00:00

  • Gonadotropin-releasing hormone (GnRH) antagonists promote proapoptotic signaling in peripheral reproductive tumor cells by activating a Galphai-coupling state of the type I GnRH receptor.

    abstract::Gonadotropin-releasing hormone (GnRH) receptor agonists are extensively used in the treatment of sex hormone-dependent cancers via the desensitization of pituitary gonadotropes and consequent decrease in steroid sex hormone secretion. However, evidence now points to a direct inhibitory effect of GnRH analogs on cancer...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-04-1360

    authors: Maudsley S,Davidson L,Pawson AJ,Chan R,López de Maturana R,Millar RP

    更新日期:2004-10-15 00:00:00

  • Adenovirus-mediated overexpression of the transcription factor E2F-1 induces apoptosis in human breast and ovarian carcinoma cell lines and does not require p53.

    abstract::Apoptosis is a mode of cell death that is carefully regulated based on cellular and environmental signals. The ability to modulate the individual cellular machinery and thereby to promote apoptosis is an important strategy in cancer therapy. It has previously been shown that overexpression of the transcription factor ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Hunt KK,Deng J,Liu TJ,Wilson-Heiner M,Swisher SG,Clayman G,Hung MC

    更新日期:1997-11-01 00:00:00

  • Lack of correlation between p53-dependent transcriptional activity and the ability to induce apoptosis among 179 mutant p53s.

    abstract::Tumor suppressor p53-dependent apoptosis is thought to be one of the most important tumor-suppressive functions in human tumorigenesis. However, whether the major mechanism underlying the p53-dependent apoptosis is transactivation dependent or independent remains unclear. Using 179 mutant p53s with diverse transcripti...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-04-2935

    authors: Kakudo Y,Shibata H,Otsuka K,Kato S,Ishioka C

    更新日期:2005-03-15 00:00:00

  • Amplification of the c-myc oncogene during progression of radiation-induced rat skin tumors.

    abstract::Evaluation of a large panel of radiation-induced rat skin tumors of diverse size and histological type revealed a correlation between c-myc copy number and tumor size. Both the frequency and degree of c-myc gene amplification were increased in large compared to small carcinomas, but none of the sarcomas examined showe...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Garte SJ,Burns FJ,Ashkenazi-Kimmel T,Felber M,Sawey MJ

    更新日期:1990-05-15 00:00:00

  • No evidence for the presence of an imprinted neuroblastoma suppressor gene within chromosome sub-band 1p36.3.

    abstract::Deletion of the distal short arm of chromosome 1 occurs in 35% of primary neuroblastomas (NBs). These deletions tend to be large and extend to the telomere, but a common region within sub-band 1p36.3 is consistently lost. Despite intensive investigation, no candidate tumor suppressor gene within this region has been s...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Hogarty MD,Winter CL,Liu X,Guo C,White PS,Look AT,Brodeur GM,Maris JM

    更新日期:2002-11-15 00:00:00

  • Effects of physiological oxygen concentration on human tumor colony growth in soft agar.

    abstract::Cloning efficiencies of 67 fresh human tumor specimens, consisting of 29 ovarian, 10 lung, and 7 each of colon, breast, mesenchymal, and miscellaneous tumors, from 58 patients were studied using the technique of Hamburger and Salmon to evaluate the effect of incubation in a 5% rather than 20% oxygen environment. Under...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Sridhar KS,Plasse TF,Holland JF,Shapiro M,Ohnuma T

    更新日期:1983-10-01 00:00:00

  • DNA vaccines encoding full-length or truncated Neu induce protective immunity against Neu-expressing mammary tumors.

    abstract::We generated DNA expression vectors encoding the full-length neu cDNA (designated pNeuN), the neu extracellular domain (pNeuE), or the neu extracellular and transmembrane domains (pNeuTM). The 293 cells transfected with pNeuN or pNeuTM expressed the neu extracellular domain on the surface membrane, whereas 293 cells t...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Chen Y,Hu D,Eling DJ,Robbins J,Kipps TJ

    更新日期:1998-05-01 00:00:00

  • Mechanism of action of the microtubule-targeted antimitotic depsipeptide tasidotin (formerly ILX651) and its major metabolite tasidotin C-carboxylate.

    abstract::Tasidotin (ILX-651), an orally active synthetic microtubule-targeted derivative of the marine depsipeptide dolastatin-15, is currently undergoing clinical evaluation for cancer treatment. Tasidotin inhibited proliferation of MCF7/GFP breast cancer cells with an IC(50) of 63 nmol/L and inhibited mitosis with an IC(50) ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-06-3065

    authors: Ray A,Okouneva T,Manna T,Miller HP,Schmid S,Arthaud L,Luduena R,Jordan MA,Wilson L

    更新日期:2007-04-15 00:00:00

  • Immunity to cell surface antigens and immune complex glomerulonephritis in hamsters bearing human epithelial tumors.

    abstract::A glomerulopathy in hamsters bearing human epithelial tumors is described. The tumors resulted from the s.c. implantation of human heteroploid cells (MA160) derived originally from a benign prostatic adenoma. The renal immunomorphological and ultrastructural changes include expansion of mesangial matrix and cellularit...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Richman AV,Alexander RW

    更新日期:1979-02-01 00:00:00

  • Inverse PCR-based RFLP scanning identifies low-level mutation signatures in colon cells and tumors.

    abstract::Detecting the presence and diversity of low-level mutations in human tumors undergoing genomic instability is desirable due to their potential prognostic value and their putative influence on the ability of tumors to resist drug treatment and/or metastasize. However, direct measurement of these genetic alterations in ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.can-03-3652

    authors: Liu WH,Kaur M,Wang G,Zhu P,Zhang Y,Makrigiorgos GM

    更新日期:2004-04-01 00:00:00

  • DNA damage and repair in L1210 cells exposed to 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.

    abstract::The DNA of L1210 cells exposed to low concentrations of 1-(2-chloroethyl)=3-cyclohexyl-1-nitrosourea has been analyzed for the presence of single-strand breaks. DNA from 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea-treated cells both sediments more slowly than control DNA on alkaline sucrose gradients andshows a great...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Hilton J,Bowie DL,Gutin PH,Zito DM,Walker MD

    更新日期:1977-07-01 00:00:00

  • A mutator phenotype characterizes one of two complementation groups in human cells tolerant to methylation damage.

    abstract::Sixty % of clones isolated from HeLa cells treated with toxic concentrations of a methylating carcinogen showed increased resistance to the cytotoxicity of N-methyl-N-nitrosourea. D37 values were 6- to 100-fold higher than in the parental cell population. The absence of detectable levels of the repair enzyme O6-methyl...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Aquilina G,Hess P,Fiumicino S,Ceccotti S,Bignami M

    更新日期:1995-06-15 00:00:00

  • Association of circulating immune complexes with cytogenetic abnormalities but not with prognosis in acute nonlymphocytic leukemia.

    abstract::Sera from 91 adult acute nonlymphocytic leukemia patients were tested for circulating immune complexes by the C1q binding test. In 42 patients tested prior to the initiation of therapy, C1q binding activity was inversely correlated with leukemic infiltrate of the bone marrow (rs = -0.34, p less than 0.02), but it was ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Crane MM,Rossen RD,McCredie KB,Trujillo JM

    更新日期:1984-07-01 00:00:00

  • Mapping of ER gene CpG island methylation-specific polymerase chain reaction.

    abstract::Southern analysis has shown that DNA from 25% of primary estrogen receptor (ER) alpha-negative breast tumors displays aberrant methylation at one site within the ER gene CpG island. To examine more sites and increase sensitivity, we developed a methylation-specific PCR assay to map methylation of the entire ER CpG isl...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Lapidus RG,Nass SJ,Butash KA,Parl FF,Weitzman SA,Graff JG,Herman JG,Davidson NE

    更新日期:1998-06-15 00:00:00

  • Osteoprotegerin prevents and reverses hypercalcemia in a murine model of humoral hypercalcemia of malignancy.

    abstract::Osteoprotegerin (OPG), a novel, secreted tumor necrosis factor receptor family member that inhibits osteoclast formation and activity was examined for its activity in a syngeneic tumor model of humoral hypercalcemia of malignancy. Normal mice bearing Colon-26 tumors develop increases in both parathyroid hormone-relate...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Capparelli C,Kostenuik PJ,Morony S,Starnes C,Weimann B,Van G,Scully S,Qi M,Lacey DL,Dunstan CR

    更新日期:2000-02-15 00:00:00

  • Tobacco smoke induces urokinase-type plasminogen activator and cell invasiveness: evidence for an epidermal growth factor receptor dependent mechanism.

    abstract::Multiple tobacco smoke-related premalignant and malignant lesions develop synchronously or metachronously in various organ sites, including the oral cavity. Both field cancerization and clonal migration seem to contribute to the occurrence of multiple tumors. Although the importance of endogenous factors (e.g., oncoge...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-1388

    authors: Du B,Leung H,Khan KM,Miller CG,Subbaramaiah K,Falcone DJ,Dannenberg AJ

    更新日期:2007-09-15 00:00:00